ProPhase Labs announces common stock offering, no amount given

ProPhase Labs (PRPH) announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of common stock are being offered by the company. ProPhase intends to use the net proceeds from this offering for working capital and general corporate purposes, which may include capital expenditures, product development and commercialization expenditures, and acquisitions of companies, businesses, technologies and products within and outside the diagnostic services, genomics and consumer products industry. ThinkEquity is acting as sole book-running manager for the offering.